vs
Side-by-side financial comparison of Distribution Solutions Group, Inc. (DSGR) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Distribution Solutions Group, Inc. is the larger business by last-quarter revenue ($518.0M vs $493.8M, roughly 1.0× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 1.2%, a 5.6% gap on every dollar of revenue. On growth, Distribution Solutions Group, Inc. posted the faster year-over-year revenue change (10.7% vs -1.7%). Over the past eight quarters, Distribution Solutions Group, Inc.'s revenue compounded faster (13.1% CAGR vs -0.1%).
Univar Solutions Inc. is a global chemical and ingredients distributor and provider of value-added services.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
DSGR vs MD — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $518.0M | $493.8M |
| Net Profit | $6.5M | $33.7M |
| Gross Margin | 32.9% | — |
| Operating Margin | 4.6% | 9.9% |
| Net Margin | 1.2% | 6.8% |
| Revenue YoY | 10.7% | -1.7% |
| Net Profit YoY | -70.6% | 10.5% |
| EPS (diluted) | $0.14 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $493.8M | ||
| Q3 25 | $518.0M | $492.9M | ||
| Q2 25 | $502.4M | $468.8M | ||
| Q1 25 | $478.0M | $458.4M | ||
| Q4 24 | $480.5M | $502.4M | ||
| Q3 24 | $468.0M | $511.2M | ||
| Q2 24 | $439.5M | $504.3M | ||
| Q1 24 | $416.1M | $495.1M |
| Q4 25 | — | $33.7M | ||
| Q3 25 | $6.5M | $71.7M | ||
| Q2 25 | $5.0M | $39.3M | ||
| Q1 25 | $3.3M | $20.7M | ||
| Q4 24 | $-25.9M | $30.5M | ||
| Q3 24 | $21.9M | $19.4M | ||
| Q2 24 | $1.9M | $-153.0M | ||
| Q1 24 | $-5.2M | $4.0M |
| Q4 25 | — | — | ||
| Q3 25 | 32.9% | — | ||
| Q2 25 | 33.9% | — | ||
| Q1 25 | 34.3% | — | ||
| Q4 24 | 33.3% | — | ||
| Q3 24 | 33.9% | — | ||
| Q2 24 | 34.5% | — | ||
| Q1 24 | 34.5% | — |
| Q4 25 | — | 9.9% | ||
| Q3 25 | 4.6% | 13.8% | ||
| Q2 25 | 5.3% | 12.8% | ||
| Q1 25 | 4.2% | 7.0% | ||
| Q4 24 | 4.2% | 7.8% | ||
| Q3 24 | 4.0% | 6.6% | ||
| Q2 24 | 3.2% | -31.3% | ||
| Q1 24 | 0.7% | 3.2% |
| Q4 25 | — | 6.8% | ||
| Q3 25 | 1.2% | 14.5% | ||
| Q2 25 | 1.0% | 8.4% | ||
| Q1 25 | 0.7% | 4.5% | ||
| Q4 24 | -5.4% | 6.1% | ||
| Q3 24 | 4.7% | 3.8% | ||
| Q2 24 | 0.4% | -30.3% | ||
| Q1 24 | -1.3% | 0.8% |
| Q4 25 | — | $0.40 | ||
| Q3 25 | $0.14 | $0.84 | ||
| Q2 25 | $0.11 | $0.46 | ||
| Q1 25 | $0.07 | $0.24 | ||
| Q4 24 | $-0.55 | $0.37 | ||
| Q3 24 | $0.46 | $0.23 | ||
| Q2 24 | $0.04 | $-1.84 | ||
| Q1 24 | $-0.11 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $69.2M | $375.2M |
| Total DebtLower is stronger | $665.5M | $570.5M |
| Stockholders' EquityBook value | $653.9M | $865.9M |
| Total Assets | $1.8B | $2.2B |
| Debt / EquityLower = less leverage | 1.02× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $375.2M | ||
| Q3 25 | $69.2M | $340.1M | ||
| Q2 25 | $47.4M | $224.7M | ||
| Q1 25 | $65.4M | $99.0M | ||
| Q4 24 | $66.5M | $229.9M | ||
| Q3 24 | $61.3M | $103.8M | ||
| Q2 24 | $46.8M | $19.4M | ||
| Q1 24 | $73.1M | $8.0M |
| Q4 25 | — | $570.5M | ||
| Q3 25 | $665.5M | $577.2M | ||
| Q2 25 | $675.0M | $583.9M | ||
| Q1 25 | $712.4M | $590.5M | ||
| Q4 24 | $693.9M | $597.1M | ||
| Q3 24 | $704.1M | — | ||
| Q2 24 | $573.7M | — | ||
| Q1 24 | $535.7M | — |
| Q4 25 | — | $865.9M | ||
| Q3 25 | $653.9M | $890.7M | ||
| Q2 25 | $649.4M | $833.8M | ||
| Q1 25 | $636.7M | $789.2M | ||
| Q4 24 | $640.5M | $764.9M | ||
| Q3 24 | $680.8M | $732.5M | ||
| Q2 24 | $653.3M | $706.5M | ||
| Q1 24 | $654.7M | $856.2M |
| Q4 25 | — | $2.2B | ||
| Q3 25 | $1.8B | $2.2B | ||
| Q2 25 | $1.8B | $2.1B | ||
| Q1 25 | $1.8B | $2.0B | ||
| Q4 24 | $1.7B | $2.2B | ||
| Q3 24 | $1.8B | $2.1B | ||
| Q2 24 | $1.6B | $2.0B | ||
| Q1 24 | $1.5B | $2.2B |
| Q4 25 | — | 0.66× | ||
| Q3 25 | 1.02× | 0.65× | ||
| Q2 25 | 1.04× | 0.70× | ||
| Q1 25 | 1.12× | 0.75× | ||
| Q4 24 | 1.08× | 0.78× | ||
| Q3 24 | 1.03× | — | ||
| Q2 24 | 0.88× | — | ||
| Q1 24 | 0.82× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $38.4M | $114.1M |
| Free Cash FlowOCF − Capex | $32.9M | — |
| FCF MarginFCF / Revenue | 6.3% | — |
| Capex IntensityCapex / Revenue | 1.1% | — |
| Cash ConversionOCF / Net Profit | 5.95× | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $92.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $114.1M | ||
| Q3 25 | $38.4M | $137.3M | ||
| Q2 25 | $33.3M | $137.2M | ||
| Q1 25 | $-4.8M | $-117.5M | ||
| Q4 24 | $45.7M | $133.0M | ||
| Q3 24 | $-17.3M | $91.8M | ||
| Q2 24 | $21.4M | $107.0M | ||
| Q1 24 | $6.6M | $-125.2M |
| Q4 25 | — | — | ||
| Q3 25 | $32.9M | — | ||
| Q2 25 | $28.7M | — | ||
| Q1 25 | $-10.4M | — | ||
| Q4 24 | $41.1M | — | ||
| Q3 24 | $-20.5M | — | ||
| Q2 24 | $18.0M | — | ||
| Q1 24 | $4.2M | — |
| Q4 25 | — | — | ||
| Q3 25 | 6.3% | — | ||
| Q2 25 | 5.7% | — | ||
| Q1 25 | -2.2% | — | ||
| Q4 24 | 8.6% | — | ||
| Q3 24 | -4.4% | — | ||
| Q2 24 | 4.1% | — | ||
| Q1 24 | 1.0% | — |
| Q4 25 | — | — | ||
| Q3 25 | 1.1% | — | ||
| Q2 25 | 0.9% | — | ||
| Q1 25 | 1.2% | — | ||
| Q4 24 | 1.0% | — | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | 0.8% | — | ||
| Q1 24 | 0.6% | — |
| Q4 25 | — | 3.39× | ||
| Q3 25 | 5.95× | 1.91× | ||
| Q2 25 | 6.66× | 3.49× | ||
| Q1 25 | -1.46× | -5.66× | ||
| Q4 24 | — | 4.36× | ||
| Q3 24 | -0.79× | 4.72× | ||
| Q2 24 | 11.28× | — | ||
| Q1 24 | — | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DSGR
| Test Equity Segment | $206.5M | 40% |
| Gexpro Services Segment | $130.5M | 25% |
| Lawson Segment | $121.5M | 23% |
| Canada Branch Division Segment | $60.0M | 12% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
